Supplements

magnesium improves glycemic control

In plain terms: Does magnesium supplementation actually improve blood sugar control?

Strong support Supplements

RefutedContestedStrong support

consensus score 0.76

Yes—especially if you're magnesium-deficient or have type-2 diabetes it lowers fasting glucose and insulin resistance, though the HbA1c effect is small and replete people see little.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

10 support 0 contradict 0 tested null 3 mixed · 13 sources, 10 independent groups · 5 superseded — pooled inside a review, counted once

What the evidence shows

Oral magnesium improves glycemic control — lowering fasting glucose and insulin resistance — in type 2 diabetes, prediabetes, and magnesium-deficient states, confirmed across multiple RCT meta-analyses. Effect concentrates in deficiency/hyperglycemia; the HbA1c change is small (Maqrashi WMD −0.16%, CI touching 0) and euglycemic replete people should not expect much.

The evidence (18)

Source	Grade	Stance	Quality	Finding
ELDerawi et al. 2018 · Nutrients	RCT	supports	moderate	T2D RCT: Mg supplementation improved glycemic response and insulin indices. ↩ SUPERSEDED — pooled in the review above, counted once
Papagiannidou A et al 2026 · study_type: observational	observational	supports	low	Narrative synthesis of RCT meta-analyses: Mg supplementation gives 'modest but clinically relevant' glycemic-control improvement, esp. in baseline-hypomagnesemic subjects
Konur K et al 2026 · study_type: observational	observational	mixed	low	Retrospective n=502 T2DM; poor glycemic control had lower serum Mg (group difference), but ROC AUC=0.41 (no predictive value)
Eriksson & Kohvakka 1995 · Ann Nutr Metab	RCT	contradicts	low	NIDDM crossover RCT: Mg gave NO glycemic/lipid benefit (ascorbic acid did); only IDDM BP fell. ↩ SUPERSEDED — pooled in the review above, counted once
Zhao et al. 2020 · Diabetes Metab Res Rev	meta-analysis	supports	moderate	SR + trial-sequential analysis (26 RCTs): Mg reduced FPG (SMD -0.32), 2h-OGTT, fasting insulin, HOMA-IR (-0.41); benefits stable.
Talari et al. 2019 · Br J Nutr	RCT	supports	moderate	Diabetic haemodialysis RCT (250 mg/d MgO, 24 wk): HbA1c -0.74%, insulin/HOMA-IR down, QUICKI up vs placebo. ↩ SUPERSEDED — pooled in the review above, counted once
Rodriguez-Moran & Guerrero-Romero 2003 · Diabetes Care	RCT	supports	moderate	Low-Mg T2D RCT (MgCl2 solution): improved insulin sensitivity and metabolic control. ↩ SUPERSEDED — pooled in the review above, counted once
Sri B et al 2026 · study_type: observational	observational	supports	low	Cross-sectional n=55 T2DM; hypomagnesemia group HbA1c 9.72±2.85% vs normal-Mg 7.65±1.94% (p=0.011); Mg inversely correlated w/ HbA1c r=-0.41
Basit et al. 2026 · J Diabetes Metab Disord	meta-analysis	supports	moderate	SR/MA in prediabetic adults: oral Mg improves glycemic and cardiometabolic outcomes; Mg central to insulin signaling, deficiency linked to insulin resistance.
de Lordes Lima et al. 1998 · Diabetes Care	RCT	supports	low	T2D increasing-dose RCT (MgO): improved metabolic control in hypomagnesemic patients.
Maqrashi et al. 2025 · Sultan Qaboos Univ Med J	meta-analysis	supports	moderate	MA 23 RCTs (n=1345): serum Mg +0.69 mmol/L, fasting glucose WMD -0.58 mmol/L; HbA1c only -0.16% (CI -0.32..0.00), larger in age>=65 & longer duration.
Yang et al. 2026 · Front Nutr	RCT	mixed	moderate	Prediabetic older adults with hypomagnesemia (RCT): oral Mg improved glycemic parameters vs placebo.
Navarrete-Cortes et al. 2014 · Magnes Res	RCT	contradicts	moderate	Normomagnesemic T2D crossover RCT (n=98): NO change in fasting glucose, HbA1c, insulin or HOMA-IR — no benefit absent deficiency. ↩ SUPERSEDED — pooled in the review above, counted once
Song et al. 2006 · Diabet Med	meta-analysis	supports	moderate	MA of double-blind RCTs: oral Mg lowered fasting glucose in T2D.
Almajed N et al 2025 · study_type: observational	observational	supports	low	Cross-sectional n=1009 Saudi adults; low serum Mg (<1.7mg/dL) independently assoc. w/ prediabetes OR=1.9 (95% CI 1.3-2.8)
Kazemi et al. 2022 · Diabetes Res Clin Pract	meta-analysis	mixed	moderate	Network MA of nutritional supplements for glycemic control: Mg among effective agents but not top-ranked across all glycemic markers.
Fatima Zaidi SN et al 2026 · study_type: animal	animal	supports	low	Fructose-induced T2DM rats; MgSO4 tx significantly (p<0.05) reduced insulin, insulin resistance vs diabetic controls
Veronese et al. 2016 · Eur J Clin Nutr	meta-analysis	supports	moderate	MA 18 RCTs (diabetes/high-risk): Mg reduced fasting plasma glucose (SMD -0.40).

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.